Is this you?
Request access for Palm Research Center with your @palmresearchcenter.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall83Recruit63Ops88Sponsor97Ther89
Performance (observed)
Historical trials
716
Completed
485
Terminated/Withdrawn
95
Completion rate
84%
Active now
121
Phase 2
192
Phase 3
412
Realized enrollment
988,913
First study year
1994
Years active
32
Match confidence
low
Enrollment velocity (inf)
30,904
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
582
States
Nevada
Recruitment (web observed)
Capability notes
5 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
Eli Lilly and Company; Pfizer; Novo Nordisk A/S; AbbVie; Allergan; Bristol-Myers Squibb
CROs
Acrotech Biopharma Inc.; Green Cross Corporation; ICON Clinical Research; MacroGenics; Medpace, Inc.; Microbiome Health Sciences
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
raffaela@palmresearchcenter.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 5 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall83
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.